| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |